RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000084.xml
Synthesis 2006(18): 2993-2995
DOI: 10.1055/s-2006-942544
DOI: 10.1055/s-2006-942544
SHORTPAPER
© Georg Thieme Verlag Stuttgart · New York
A Novel Method for the Introduction of Fluorine into the Purine 2-Position: Synthesis of 2-Fluoroadenosine and a Formal Synthesis of the Antileukemic Drug Fludarabine
Weitere Informationen
Received
23 April 2006
Publikationsdatum:
02. August 2006 (online)
Publikationsverlauf
Publikationsdatum:
02. August 2006 (online)
Abstract
A novel method for the introduction of fluorine in the purine 2-position is described and employed in the synthesis of a potential antimycobacterial compound. Also 2-fluoroadenosine has been synthesized for the first time from adenosine with perbenzoylated 2-nitroadenosine as a key intermediate. Mild reaction conditions are employed and few synthetic steps are required. The novel synthesis of fluoroadenosine can be regarded as a formal synthesis of the antileukemic drug fludarabine phosphate.
Key words
anticancer agents - fluorination - nitration - nucleosides - purines
- 1
Rosemeyer H. Chem. Biodiversity 2004, 1: 361 - 2
Seela F.Ramzaeva N.Rosemeyer H. In Science of Synthesis Vol. 16:Yamamoto Y. Thieme; Stuttgart: 2004. p.1945 ; and references therein -
3a
Deghati PYF.Wanner MJ.Koomen G.-J. Tetrahedron Lett. 2000, 41: 1291 -
3b
Rodenko B.Koch M.Van der Burg AM.Wanner MJ.Koomen G.-J. J. Am. Chem. Soc. 2005, 127: 5957 -
4a
Wanner MJ.Von Frijtag Drabbe Künzel JK.Ijzerman AP.Koomen G.-J. Bioorg. Med. Chem. Lett. 2000, 10: 2141 -
4b
Rodenko B.Wanner MJ.Koomen G.-J. J. Chem. Soc., Perkin Trans. 1 2002, 1247 -
5a
Wanner MJ.Koomen G.-J. J. Chem. Soc., Perkin Trans. 1 2001, 1908 -
5b
Beukers MW.Wanner MJ.Von Frijtag Drabbe Künzel JK.Klaasse EC.Ijzerman AP.Koomen G.-J. J. Med. Chem. 2003, 46: 1492 -
5c
Wanner MJ.Koch M.Koomen G.-J. J. Med. Chem. 2004, 47: 6875 - 6
Kuduk SD.DiPardo RM.Bock MG. Org. Lett. 2005, 7: 577 -
7a
Bakkestuen AK.Gundersen L.-L.Langli G.Liu F.Nolsøe JMJ. Bioorg. Med. Chem. Lett. 2000, 10: 1207 -
7b
Gundersen L.-L.Nissen-Meyer J.Spilsberg B. J. Med. Chem. 2002, 45: 1383 -
7c
Bakkestuen AK.Gundersen L.-L.Utenova BT. J. Med. Chem. 2005, 48: 2710 -
7d
Brændvang M.Gundersen L.-L. Bioorg. Med. Chem. 2005, 13: 6360 - 8
Bauman JG, andWirsching RC. inventors; PCT Int. Appl. WO 9412514, . Chem. Abstr. 1995, 122, 133691 - 9 See for instance:
Nabhan C.Gartenhaus RB.Tallman MS. Leukemia Res. 2004, 28: 429 - For some recent examples of bioactive 2-fluoropurines, see:
-
10a
Qin X.Chen X.Wang K.Polin L.Kern ER.Drach JC.Gullen E.Cheng Y.-C.Zemlicka J. Bioorg. Med. Chem. 2006, 14: 1247 -
10b
He H.Zatorska D.Kim J.Aguirre J.Llauger L.She Y.Wu N.Immormino RM.Gewirth DT.Chiosis G. J. Med. Chem. 2006, 49: 381 -
10c
Takagi C.Sukeda M.Kim H.-S.Wataya Y.Yabe S.Kitade Y.Matsuda A.Shuto S. Org. Biomol. Chem. 2005, 3: 1245 -
10d
Ye S.Rezende M.Deng W.-P.Herbert B.Daly JW.Johnson RA.Kirk KL. J. Med. Chem. 2004, 47: 1207 -
10e
Hutchinson SA.Baker SP.Linden J.Scammells PJ. Bioorg. Med. Chem. 2004, 12: 4877 - 11
Brown GA,Savory ED,Ouzman JVA, andStoddart AM. inventors; PCT Int. Appl. WO 2005056571, . Chem. Abstr. 2005, 143, 60193 - 12
Montgomery JA. J. Am. Chem. Soc. 1960, 82: 463